Comparison of computed tomography-and optical image-based assessment of liposome distribution

Molecular Imaging

Volumn 12, Issue 3, 2013, Pages

  Huang, Huang ^a   Dunne, Michael ^a   Lo, John ^a   Jaffray, David A ^a   Allen, Christine ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; COMPUTED TOMOGRAPHIC; FLUORESCENCE MOLECULAR TOMOGRAPHY; HIGH SENSITIVITY; MICROSCOPIC DISTRIBUTION; MULTI-MODAL IMAGING; NON SMALL CELL LUNG CANCER; OPTICAL IMAGING;

AUTOMOBILE BODIES; GEOMETRICAL OPTICS; LIPOSOMES; OPTICAL IMAGE STORAGE; TOMOGRAPHY; TUMORS;

COMPUTERIZED TOMOGRAPHY;

IOHEXOL; LIPOSOME;

ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FLUORESCENCE IMAGING; HUMAN; LUNG TUMOR; METABOLISM; MOUSE; PROCEDURES; THREE DIMENSIONAL IMAGING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; IOHEXOL; LIPOSOMES; LUNG NEOPLASMS; MICE; OPTICAL IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879234736     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2012.00028     Document Type: Article

References (49)

1. Torchilin VP. Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 2007;9:E128-E147, doi:10.1208/aapsj0902015.
2. Tashjian JA, Dewhirst MW, Needham D, Viglianti BL. Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques. Int J Hyperthermia 2008;24:79-90, doi:10.1080/ 02656730701840147.
3. Palko HA, Fung JY, Louie AY. Positron emission tomography: a novel technique for investigating the biodistribution and transport of nanoparticles. Inhal Toxicol 2010;22:657-68, doi:10.3109/08958371003713745.
4. Chrastina A, Schnitzer JE. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomed 2010;5: 653-9.
5. Beckmann N, Cannet C, Babin AL, et al. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009;1:272-98, doi:10.1002/wnan.16.
6. Zheng J, Perkins G, Kirilova A, et al. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications. Invest Radiol 2006;41:339-48, doi:10.1097/01.rli.0000186568.50265.64.
7. von Wallbrunn A, Waldeck J, Holtke C, et al. In vivo optical imaging of CD13/APN-expression in tumor xenografts. J Biomed Opt 2008;13:011007, doi:10.1117/1.2839046.
8. Strijkers G, Kluza E, Van Tilborg G, et al. Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis 2010;13:161-73, doi:10.1007/s10456-010-9165-1.
9. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2003;2:123-31, doi:10.1038/nrd1007.
10. Ntziachristos V, Tung CH, Bremer C, Weissleder R. Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 2002;8:757-60, doi:10.1038/nm729.
11. Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature 2008;452:580-9, doi:10.1038/nature06917.
12. Schulz RB, Ale A, Sarantopoulos A, et al. Hybrid system for simultaneous fluorescence and x-ray computed tomography. IEEE Trans Med Imaging 2010;29:465-73, doi:10.1109/TMI.2009.2035310.
13. Guo X, Liu X, Wang X, et al. A combined fluorescence and microcomputed tomography system for small animal imaging. IEEE Trans Biomed Eng 2010;57:2876-83, doi:10.1109/TBME.2010.2073468.
14. Davis SC, Pogue BW, Springett R, et al. Magnetic resonancecoupled fluorescence tomography scanner for molecular imaging of tissue. Rev Sci Instrum 2008;79:064302-1-064302-10, doi:10.1063/1.2919131.
15. Ntziachristos V, Yodh AG, Schnall M, Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci U S A 2000;97:2767-72, doi:10.1073/pnas.040570597.
16. Ntziachristos V, Ma XH, Chance B. Time-correlated single photon counting imager for simultaneous magnetic resonance and nearinfrared mammography. Rev Sci Instrum 1998;69:4221-33, doi:10.1063/1.1149235.
17. Mikhaylova M, Stasinopoulos I, Kato Y, et al. Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. Cancer Gene Ther 2009;16:217-26.
18. Mulder WJM, Strijkers GJ, Griffioen AW, et al. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 2004;15:799-806, doi:10.1021/bc049949r.
19. Kamaly N, Kalber T, Ahmad A, et al. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug Chem 2008;19:118-29, doi:10.1021/bc7001715.
20. Zielhuis SW, Seppenwoolde JH, Mateus VAP, et al. Lanthanideloaded liposomes for multimodality imaging and therapy. Cancer Biother Radiopharm 2006;21:520-7, doi:10.1089/cbr.2006.21.520.
21. Gopalakrishnan G, Danelon C, Izewska P, et al. Multifunctional lipid/quantum dot hybrid nanocontainers for controlled targeting of live cells. Angew Chem Int Ed Engl 2006;45:5478-83, doi:10.1002/anie.200600545.
22. Mulder WJM, Strijkers GJ, Habets JW, et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J 2005;19:2008-10.
23. Hoang B, Lee H, Reilly RM, Allen C. Noninvasive monitoring of the fate of 111In-labeled block copolymer micelles by high resolution and high sensitivity microSPECT/CT imaging. Mol Pharm 2009;6:581-92, doi:10.1021/mp8002418.
24. Mikhail AS, Allen C. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. J Control Release 2009;138:214-23, doi:10.1016/j.jconrel.2009.04.010.
25. Zheng J, Liu J, Dunne M, et al. In vivo performance of a liposomal vascular contrast agent for CT and MR-based image guidance applications. Pharm Res 2007;24:1193-201, doi:10.1007/s11095-006-9220-1.
26. Zheng J, Jaffray D, Allen C. Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model. Mol Pharm 2009;6:571-80, doi:10.1021/mp800234r.
27. Song S, Liu D, Peng J, et al. Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo. FASEB J 2009;23:1396-404, doi:10.1096/fj.08-117002.
28. Song S, Liu D, Peng J, et al. Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int J Pharm 2008;363:155-61, doi:10.1016/j.ijpharm.2008.07.012.
29. Southwick PL, Ernst LA, Tauriello EW, et al. Cyanine dye labeling reagents - carboxymethylindocyanine succinimidyl esters. Cytometry 1990;11:418-30, doi:10.1002/cyto.990110313.
30. Mujumdar RB, Ernst LA, Mujumdar SR, et al. Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters. Bioconjug Chem 1993;4:105-11, doi:10.1021/bc00020a001.
31. Parr MJ, Ansell SM, Choi LS, Cullis PR. Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles. Biochim Biophys Acta Biomembr 1994;1195:21-30, doi:10.1016/0005-2736(94)90004-3.
32. Shmeeda H, Mak L, Tzemach D, et al. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol Cancer Ther 2006;5:818-24, doi:10.1158/1535-7163.MCT-05-0543.
33. Bonté F, Juliano RL. Interactions of liposomes with serum proteins. Chem Phys Lipids 1986;40:359-72, doi:10.1016/0009-3084(86)90079-4.
34. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 2006;11:812-8, doi:10.1016/j.drudis.2006.07.005.
35. Torchilin VP. Passive and active drug targeting: drug delivery to tumors as an example. In: Scha?fer-Korting M, editor. Drug delivery. Vol 197. Handbook of experimental pharmacology. Berlin: Springer; 2010. p. 3-53.
36. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92.
37. Gao M, Lewis G, Turner GM, et al. Effects of background fluorescence in fluorescence molecular tomography. Appl Opt 2005;44:5468-74, doi:10.1364/AO.44.005468.
38. Garofalakis A, Dubois A, Kuhnast B, et al. In vivo validation of free-space fluorescence tomography using nuclear imaging. Opt Lett 2010;35:3024-6, doi:10.1364/OL.35.003024.
39. Barber WC, Lin Y, Nalcioglu O, et al. Combined fluorescence and x-ray tomography for quantitative in vivo detection of fluorophore. Technol Cancer Res Treat 2010;9:45-51.
40. Correia T, Aguirre J, Sisniega A, et al. Split operator method for fluorescence diffuse optical tomography using anisotropic diffusion regularisation with prior anatomical information. Biomed Opt Express 2011;2:2632-48, doi:10.1364/BOE.2.002632.
41. Nahrendorf M, Keliher E, Marinelli B, et al. Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A 2010;107: 7910-5, doi:10.1073/pnas.0915163107.
42. Wu K, Ung YC, Hornby J, et al. PET CT thresholds for radiotherapy target definition in non-small-cell lung cancer: how close are we to the pathologic findings? Int J Radiat Oncol Biol Phys 2010;77:699-706, doi:10.1016/j.ijrobp. 2009.05.028.
43. Erdi YE, Mawlawi O, Larson SM, et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding. Cancer 1997;80(12 Suppl):2505-9, doi:10.1002/(SICI) 1097-0142(19971215)80:12+,2505::AID-CNCR24.3. 0.CO;2-F.
44. Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET). Radiother Oncol 2002;62: 51-60, doi:10.1016/S0167-8140(01)00470-4.
45. Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;59:78-86, doi:10.1016/j.ijrobp.2003.10.044.
46. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 2002;53: 353-9, doi:10.1016/S0360-3016(02) 02705-0.
47. Vines DC, Keller H, Hoisak JDP, Breen SL. Quantitative PET comparing gated with nongated acquisitions using a NEMA phantom with respiratory-simulated motion. J Nucl Med Technol 2007;35:246-51, doi:10.2967/jnmt.107.040782.
48. Speck U. Contrast agents: x-ray contrast agents and molecular imaging - a contradiction? Handb Exp Pharmacol 2008(185 Pt 1): 167-75.
49. Johnson SM, Bangham AD, Hill MW, Korn ED. Single bilayer liposomes. Biochim Biophys Acta Biomembr 1971;223:820-6, doi:10.1016/0005-2736(71)90273-2.